AzTrials
AzTrials

Early Childhood DevelopmentSUpErCDZNCT03991182

Evaluation of Scaling Up Early Childhood Development in Zambia

A study testing SMAGs trained on ECD curriculum, Head women trained on ECD curriculum and Head women led parent groups in people with Early Childhood Development, run by Boston University at 3 sites in Zambia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In Zambia, 40% of children under five years of age are stunted and 6% are wasted. While the Zambian government has focused on child nutrition in recent years, more focus on holistically improving early child development (ECD) is needed. Read more about this study

Who is it for?
Ages 0 months and olderHealthy volunteers can take part
Conditions the study is for
Early Childhood Development
What is being tested?
SMAGs trained on ECD curriculum, Head women trained on ECD curriculum and Head women led parent groups
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,108 participants
Where
3 sitesZambia
Study dates
20 Sep 2019to 31 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 months and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Children aged 0-5 months at baseline in the catchment areas of the ten selected health facilities in Southern and Eastern Provinces will be eligible to participate
  • Child's primary caregiver must be 15 years or older
  • Child's primary caregiver must be a female (because the participants in the women's group may feel uncomfortable discussing certain issues if a man is present)
  • A member of the health facility staff at a study site for at least 6 months; or
  • A district or provincial level health staff; or
  • A SMAG member at a study site who has been trained to implement the parenting group intervention; or
Show all 10Show fewer
  • A 'head mother' leading parenting group sessions within their communities; and ≥18 years of age and provided informed consent to participate in the IDI.
  • A woman or a man with child under 3 years of age; or
  • Community health volunteers [SMAG, community health worker (CHW) or TBA]; and
  • Resident within the project zones; and -≥18 years of age

Who cannot join

  • Caregivers who are unwilling to provide informed consent
  • Families that plan to move from their health center catchment zone during the period of the study
  • In-depth interviews (IDI)
  • -None
  • Focus group discussions (FGDs)
  • -None

Trial locations and contacts

3 sites in 1 country.

Zambia3 sites
  • Choma District Medical Office

    Choma, Southern Province

  • Kalomo District Medical Office

    Kalomo, Southern Province

  • Nyimba District Medical Office

    Nyimba, Eastern Province

Other trials in Zambia

About this study

In Zambia, 40% of children under five years of age are stunted and 6% are wasted. While the Zambian government has focused on child nutrition in recent years, more focus on holistically improving early child development (ECD) is needed. Through a previous randomized controlled trial, the investigators developed a community-based parenting intervention and demonstrated that this intervention can improve children's developmental outcomes in Zambia, including nutritional status and their early language development. During fortnightly group meetings, parents learn a diverse curriculum that includes content on: 1) cognitive stimulation and play practices; 2) child nutrition and cooking practices; and 3) self-care for good mental health. This information and learning content is delivered by supervised community volunteers using an interactive theatre-based approach.

In this study, the newly established maternity waiting homes (MWHs) and affiliated Safe Motherhood Action Group leaders (SMAGs) will be used as a novel platform to launch and support community-based parenting groups, embedding this program directly into the existing health system, and making them more feasible for scale-up and sustainability.

Despite the positive impact of the proposed parenting-group model in the pilot trial, this model is not currently operating in Zambia. By integrating this intervention into the existing health system, large populations of rural children exposed to high levels of adversity in the critical early years of life could be reached in a nationally scalable fashion. As part of this project, the investigators propose to implement and rigorously assess the impact of this approach in four districts of Zambia.

Read the detailed description

This research will utilize a cluster-randomized controlled trial with integrated mixed-methods process evaluation to understand the impact of parenting groups on child development outcomes when delivered at scale. The specific objectives are to: 1) assess the impact of the intervention on early childhood development outcomes; 2) assess the degree to which the intervention was implemented according to the project plan and to document adjustments made during the course of the project; 3) describe and document the perceptions of caregivers on parent groups, as well as any behavioral changes in parenting or in mother support networks resulting from participating in parenting groups; and approaches to achieving caregiving gender equality at household level; and, 4) generate a set of recommendations for the Government of the Republic of Zambia to further adapt and/or scale up community parenting groups based on the summative findings from this study.

For the impact evaluation the investigators will collect data from two main sources: 1) Household Surveys and 2) In-depth interviews at both baseline and endline data collection. In addition, at endline we will assess child development using the Malawi Developmental Assessment Tool (MDAT).

For the process evaluation, the investigators will conduct record review of parenting groups attendance registers and SMAG log books. The investigators will conduct in-depth interviews with health systems staff (province, district and health facility), SMAGs, and head women from all intervention sites, and focus group discussions with caregivers who meet the study eligibility criteria in both intervention and control zones.

Being tested
SMAGs trained on ECD curriculum, Head women trained on ECD curriculum, Head women led parent groups, Usual care of children 0-5 months
Keywords
Community based parenting, Developmental outcomes, Maternity waiting homes (MWHs), Safe Motherhood Action Group leaders (SMAGs), Zambia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SMAGs trained on ECD curriculumOther

    50 volunteers (primarily SMAGs- Safe Motherhood Action Group members) associated with the health facility will be trained using a training -of-trainers approach on the e ECD (early childhood development) curriculum

  • Head women trained on ECD curriculumOther

    Each of the 50 trained SMAGs will train 10 head women on the ECD curriculum

  • Head women led parent groupsBehavioural

    Every two weeks 500 trained head women lead parent group meetings on childhood development and nutrition to caregiver-child dyads

  • Usual care of children 0-5 monthsOther

    The traditional care and education of caregivers/parents for children 0-5 months

Study groups in NCT03991182
Study groupRoleWhat they receive
Community-based parenting groupExperimentalThe community-based parenting group will include 39 health zones and 585 caregiver-child dyads
Receives: Other: SMAGs trained on ECD curriculum; Other: Head women trained on ECD curriculum; Behavioral: Head women led parent groups
Control groupActive comparatorThe control group will include 39 health zones and 585 caregiver-child dyads
Receives: Other: Usual care of children 0-5 months

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Child linear growth: Stunting

    Heights of all study children will be measured. Height-for-age z-scores will be calculated using standard World Health Organization (WHO) criteria. Stunting will be defined as having a height-for-age z-score < -2. The difference in the prevalence of stunting between children in the intervention and comparison areas will be determined.

    Measured: Children aged 0-5 months at baseline (August-September 2019) and end line (September 2021), child aged 24-29 months

  2. Child development z-scores based on Malawi Developmental Assessment Tool (MDAT)

    Cognitive function measurements

    Measured: At endline (child aged 24-29 months) children are assessed using the MDAT. Scores are standardized within the study sample for analysis.

  3. Caregiver Reported Early Development Index

    Summary score of child development measures (motor, cognitive, language, and social emotional skills)

    Measured: Children aged 0-5 months at baseline (August-September 2019) and end line (September 2021), child aged 24-29 months

Secondary outcomes (5)
  1. Proportion of children receiving all age-appropriate vaccines

    We will collect data at baseline and endline on whether the study children are up to date on vaccines as recommended by the government vaccination schedule.

    Measured: Baseline (child 0-5 months), Endline (child aged 24-29 months)

  2. Proportion of children receiving vitamin A supplementation

    Caregivers will be asked about vitamin A supplementation and responses will be compared to child development outcomes

    Measured: Baseline (child 0-5 months), Endline (child aged 24-29 months)

  3. Number of well-baby visits attended

    Caregivers will be asked about the health seeking behaviors for the child; results will be compared against government recommendations and against child development outcomes

    Measured: Baseline (child 0-5 months), Endline (child aged 24-29 months)

  4. Average time spent reading with the child

    Caregivers will be asked about their engagement with the child and other adult engagement with the child at baseline and endline

    Measured: Baseline (child 0-5 months), Endline (child aged 24-29 months)

  5. Average time spent playing with the child

    Caregivers will be asked about their engagement with the child and other adult engagement with the child at baseline and endline

    Measured: Baseline (child 0-5 months), Endline (child aged 24-29 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2019
  2. Study start20 Sep 2019
  3. Primary completion30 Nov 2021
  4. Study completion31 Jan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,108 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03991182
Sponsor's protocol ID
H-38950
Other IDs
TTS-1802-21377, 72061119FA00001
Acronym
SUpErCDZ
Status last verified
Aug 2023
First submitted
14 Jun 2019
Last updated
16 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rockers PC, Zanolini A, Banda B, Chipili MM, Hughes RC, Hamer DH, Fink G. Two-year impact of community-based health screening and parenting groups on child development in Zambia: Follow-up to a cluster-randomized controlled trial. PLoS Med. 2018 Apr 24;15(4):e1002555. doi: 10.1371/journal.pmed.1002555. eCollection 2018 Apr.

    PubMed 29689045
  • Rockers PC, Fink G, Zanolini A, Banda B, Biemba G, Sullivan C, Mutembo S, Silavwe V, Hamer DH. Impact of a community-based package of interventions on child development in Zambia: a cluster-randomised controlled trial. BMJ Glob Health. 2016 Nov 22;1(3):e000104. doi: 10.1136/bmjgh-2016-000104. eCollection 2016.

    PubMed 28588962
  • Scott NA, Kaiser JL, Vian T, Bonawitz R, Fong RM, Ngoma T, Biemba G, Boyd CJ, Lori JR, Hamer DH, Rockers PC. Impact of maternity waiting homes on facility delivery among remote households in Zambia: protocol for a quasiexperimental, mixed-methods study. BMJ Open. 2018 Aug 10;8(8):e022224. doi: 10.1136/bmjopen-2018-022224.

    PubMed 30099401

Questions about this trial

What is this clinical trial studying?

A study testing SMAGs trained on ECD curriculum, Head women trained on ECD curriculum and Head women led parent groups in people with Early Childhood Development, run by Boston University at 3 sites in Zambia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Zambia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Child linear growth: Stunting (time frame: Children aged 0-5 months at baseline (August-September 2019) and end line (September 2021), child aged 24-29 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03991182, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2023; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in